Summary Icon Foods CEO Kash Rocheleau’s Q4 Market Intelligence Report underscores a pivotal moment for the food and beverage industry. As tariff volatility, ocean freight surges, and regulatory scrutiny reshape supply chains, brands are being challenged to adapt faster than ever. The report explores how macroeconomic shifts—from Fed rate cuts Read more…
Summary Global erythritol markets are entering a volatile stretch as trade actions reshape supply and pricing into 2026. With the U.S. advancing anti-dumping and countervailing duty (AD/CVD) cases against Chinese imports—and the EU already enforcing steep tariffs—buyers face tightening availability and firmer prices. Demand remains resilient across food and beverage Read more…
Summary Formulating better-for-you bars in today’s crowded market requires balancing taste, functionality, and health benefits, especially as more consumers turn to GLP-1 medications and demand nutrient-dense, low-glycemic options. This white paper highlights how Icon Foods’ sweeteners, fibers, and inclusions—such as allulose, PreBiotica™ agave inulin, FibRefine™ soluble tapioca fiber, erythritol, and Read more…
The Role of Erythritol and Xylitol in Stimulating GLP-1 Gastrointestinal Hormones: Implications for Appetite Regulationby Thom King, Icon Foods, Chief Innovations Officer/Food Scientist Erythritol and xylitol are sugar alcohols (polyols) widely used as low-calorie sweeteners. Recent studies suggest that these compounds may influence the secretion of various gastrointestinal hormones, including Read more…
By Thom King – Chief Innovations Officer Icon Foods Where does one even start? Tariffs? Cargill’s anti-dumping suit? Demand for containers? The only thing we are missing is a pandemic. We will dive into the burning dumpster in a bit but first let’s have a look at things that look Read more…
Semaglutide, commonly referred to as Ozempic[i], falls into drugs categories known as GLP-1 or Glucagon-like peptide-1 (GLP-1) agonists. Tirzepatide, commonly referred to at the brand Mounjaro[ii], falls into a dual agonist category which contain both GLP-1 and GIP, glucose-dependent insulinotropic polypeptide. Both are important classes of incretin hormones that play Read more…
The tariffs implemented in 2017, and the potential tariffs projected for 2025 reflect different economic climates, policy objectives, and international trade dynamics. Here is a comparison of these tariffs, along with their potential ramifications in the food ingredient space: 2017 Tariffs Overview: The administration introduced tariffs primarily on steel and Read more…
Icon Foods’ milling and particle reduction offers significant benefits to food formulators and manufacturers looking to enhance their products, particularly in the realm of clean label sugar reduction regarding sweeteners and sweetening systems. Improved Solubility and Consistency: By reducing particle size, sweeteners become more soluble, allowing for easier incorporation into Read more…
Market Intelligence By Thom King – Chief Innovations Officer Icon Foods Six months ago, I took a title change. [1] It was time for me to hand the reins over to the younger generation so they could get their turn. This is not a move I regret. It has given me Read more…
